Abstract:Background Systemic lupus erythematosus (SLE) is a chronic and systemic autoimmune disease, which is accompanied by abnormal activation of T/B lymphocytes, multiple autoantibodies and immune complex deposition. Granzyme B producing (GrB+) B cells are a group of new regulatory B cell subsets, which can participate in the pathogenesis of autoimmune disease, but its role in SLE is not clear. In this study, we investigate the expression level of Granzyme B producing B cells in SLE patients and lupus-like mouse models. Methods 1. Patients with SLE (n=7) meeting 1997 American College of Rheumatology revised criteria were enrolled from the Department of Rheumatology and Immunology. 15 healthy individual samples were obtained from physical examination center in our hospital. We collected 4 mL peripheral anticoagulant blood from both groups and peripheral blood mononuclear cells were isolated. The proportion of GrB +B cells in PBMC was identified by flow cytometry. 2. A lupus-like mouse model induced by transfer of spleen cells from bm12 mice was constructed. Two wildtype C57BL/c mice and two lupus-like mouse models (both 68 weeks old mice) were sacrificed by CO2anesthesia. The spleens of the mice were aseptically isolated, and the spleen single cells were obtained after grinding the tissues. The ratio of GrB +Breg cells in the spleen cells of the two groups was detected by flow cytometry (FACS). 3. SPSS24.0 software was used for statistical analysis, and p<0.05 was considered statistically significant Results 1. Using flow cytometry 7AAD label excludes dead cells, CD3 marker excludes T lymphocytes and CD56 markers exclude NK cells. After CD14 labeling excludes monocytes/macrophages, the proportion of GrB +Breg cells in peripheral blood of healthy controls was 7.52%; Compared with healthy controls, the proportion of GrB +Breg cells in peripheral blood of SLE patients (4.45%) showed a significant downward trend. 2. Compared with the wild type control mice, the proportion of GrB +Breg cells in the spleen cells of lupus mouse model (2.14%) showed a significant downward trend. Conclusions The proportion of GrB +Breg cells in the peripheral blood of SLE patients and the spleen cells of lupus-like mouse models showed a downward trend, which may be related to the pathogenesis of SLE, but the exact role remains to be further verified. Funding Source(s): This study was supported by grants from the National Natural Science Foundation of China.

Ligation of Metabotropic Glutamate Receptor 3 (grm3) Ameliorates Lupus-Like Disease by Reducing B Cells.

Metabotropic Glutamate Receptor 3 is Involved in B-cell-related Tumor Apoptosis.

Impaired regulatory function of granzyme B-producing B cells against T cell inflammatory responses in lupus mice

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity

Effect of BAFF blockade on the B cell receptor repertoire and transcriptome in a mouse model of systemic lupus erythematosus

Expressions of BAFF/BAFF Receptors and Their Correlation with Disease Activity in Chinese SLE Patients

Excessive Mir-152-3p Results in Increased BAFF Expression in SLE B-Cells by Inhibiting the KLF5 Expression

Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice

Impairment of Granzyme B-Producing Regulatory B Cells Correlates with Exacerbated Rheumatoid Arthritis.

A Small-Molecule Macrophage Migration Inhibitory Factor Antagonist Protects Against Glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/lpr Mice.

118 Granzyme B Producing B Cells in Systemic Lupus Erythematosus Patients and Lupus-Like Mouse Models

Impaired Granzyme B-producing Regulatory B Cells in Systemic Lupus Erythematosus

ORMDL3 Facilitates the Survival of Splenic B Cells via an ATF6α–Endoplasmic Reticulum Stress–Beclin1 Autophagy Regulatory Pathway

A Novel BAFF Antagonist, BAFF-Trap, Effectively Alleviates the Disease Progression of Systemic Lupus Erythematosus in MRL/lpr Mice

Systemic Blockade of Probdnf Inhibited the Expansion and Altered the Transcriptomic Expression in CD3+B220+cells in MRL/lpr Lupus Mice

Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis.

238 Leukocyte immunoglobulin-like receptor A3 (LILRA3) promotes lupus-like disease in a murine lupus model

Blockade of B-cell-activating Factor Suppresses Lupus-Like Syndrome in Autoimmune BXSB Mice

B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF

RasGRP3 in peripheral blood mononuclear cells is associated with disease activity and implicated in the development of systemic lupus erythematosus.

Gpr97/Adgrg3 Ameliorates Experimental Autoimmune Encephalomyelitis by Regulating Cytokine Expression.